Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for an upstream energy company: the income statement reflects commodity-driven profitability, the cash flow statement shows operational cash generation and capital allocation, and the balance sheet indicates leverage and liquidity resilience.

Composite Trajectory: Improving

The annual and year-to-date trends show consistent improvement across revenue, net income, operating cash flow, free cash flow, and debt reduction. FY2025 versus FY2024 shows a 27% increase in natural gas, NGLs and oil sales, a 147% increase in net income, a 24% increase in operating cash flow, and a 29% reduction in total debt (10-K FY2025, Consolidated Statements of Operations; 10-K FY2025, Consolidated Statements of Cash Flows; 10-K FY2025, Consolidated Balance Sheets). The first six months of 2026 versus the same period in 2025 show a 17% sales increase, 60% net income increase, 28% operating cash flow increase, and further debt reduction via the 8.25% 2029 notes redemption (10-Q Q2 2026, MD&A). The sole mixed signal is Q2 2026 standalone, where net income fell 18% and operating cash flow fell 30% year-over-year due to lower derivative fair value income and working capital timing, but the six-month and annual trajectories remain firmly positive (10-Q Q2 2026, MD&A).

2. Red Flags

• Quarterly earnings and cash flow divergence: Q2 2026 net income decreased 18% to $195.3 million despite a 5% revenue increase, driven by a 52% drop in derivative fair value income ($73.5 million vs $154.7 million); operating cash flow fell 30% to $235.0 million due to working capital timing (10-Q Q2 2026, MD&A).
• Rising per-unit operating costs: Direct operating expense per mcfe increased 18% in Q2 2026 ($0.13 vs $0.11) and 17% in 6M 2026 ($0.14 vs $0.12); general and administrative expense per mcfe increased 10% in both Q2 and 6M 2026 ($0.23 vs $0.21); transportation, gathering, processing and compression per mcfe increased 3% in 6M 2026 ($1.57 vs $1.53) (10-Q Q2 2026, MD&A).
• Persistent negative brokered margin: Net brokered natural gas and marketing margin was a loss of $13.0 million in FY2025 (wider than $7.5 million loss in FY2024) and a loss of $2.7 million in 6M 2026 (10-K FY2025, MD&A; 10-Q Q2 2026, MD&A).
• Increasing unproved property impairments: Abandonment and impairment of unproved properties rose to $28.9 million in FY2025 from $8.4 million in FY2024 (10-K FY2025, MD&A).
• Minimal cash balances: Cash and cash equivalents were $204 thousand at December 31, 2025 and $247 thousand at June 30, 2026, leaving the company reliant on its credit facility for liquidity (10-K FY2025, Consolidated Balance Sheets; 10-Q Q2 2026, MD&A).
• Derivative fair value volatility: Derivative fair value income swung from $56.7 million in FY2024 to $121.5 million in FY2025; in Q2 2026 it was $73.5 million versus $154.7 million in Q2 2025; in 6M 2026 it was $40.1 million versus a $4.2 million loss in 6M 2025 (10-K FY2025, Consolidated Statements of Operations; 10-Q Q2 2026, MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Annual net income rose 147% to $658.0 million in FY2025 from $266.3 million in FY2024, driven by a 27% increase in natural gas, NGLs and oil sales to $2.82 billion and a 14% increase in average realized price (including derivatives and transport) to $2.10 per mcfe (10-K FY2025, Consolidated Statements of Operations; 10-K FY2025, MD&A). Six-month 2026 net income rose 60% to $537.0 million versus $334.6 million in 6M 2025, with sales up 17% to $1.71 billion and realized price up 17% to $2.60 per mcfe (10-Q Q2 2026, MD&A). Production grew modestly (2% annually, 2% in 6M 2026). Per-unit costs were stable annually (direct operating $0.13 vs $0.12, transport $1.50 vs $1.48, G&A $0.22 flat, DD&A $0.45 flat) but increased in the 2026 interim periods as noted in Red Flags. Interest expense per mcfe fell 13% annually and 43-46% in 2026 interim periods due to debt reduction (10-K FY2025, MD&A; 10-Q Q2 2026, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Annual net cash provided by operating activities increased 24% to $1.17 billion in FY2025 from $944.5 million in FY2024; free cash flow (operating cash flow less additions to properties) rose 58% to approximately $590 million from $374 million (10-K FY2025, Consolidated Statements of Cash Flows). Six-month 2026 operating cash flow increased 28% to $854.2 million from $666.3 million in 6M 2025, while additions to properties increased 18% to $331.2 million (10-Q Q2 2026, MD&A). Capital allocation prioritized share repurchases ($230.6 million in FY2025, $105.5 million in 6M 2026) and dividends ($85.7 million in FY2025, $47.5 million in 6M 2026), alongside significant debt repayment ($608.7 million senior notes in FY2025, $608.3 million in 6M 2026) (10-K FY2025, Consolidated Statements of Cash Flows; 10-Q Q2 2026, MD&A). Q2 2026 operating cash flow declined 30% to $235.0 million due to working capital timing, but the six-month and annual trends are strongly positive (10-Q Q2 2026, MD&A).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total debt (net of issuance costs) fell 29% to $1.20 billion at December 31, 2025 from $1.70 billion at December 31, 2024, primarily through repayment of the 4.875% 2025 notes ($606.5 million) and no new senior note issuance (10-K FY2025, Consolidated Balance Sheets; 10-K FY2025, Note 6). Current liabilities dropped 48% to $661.2 million from $1.27 billion as the current maturity of long-term debt was eliminated (10-K FY2025, Consolidated Balance Sheets). Stockholders' equity increased 10% to $4.32 billion from $3.94 billion, with the retained deficit improving by $571 million (10-K FY2025, Consolidated Balance Sheets). As of June 30, 2026, the 8.25% 2029 notes ($600 million) were redeemed, reducing senior notes to $500 million (4.75% 2030); bank credit facility balance was $381 million with $1.5 billion available, maintaining $1.5 billion total liquidity (10-Q Q2 2026, MD&A). The debt-to-EBITDAX covenant remained in compliance (10-K FY2025, Note 6).

6. Data Gaps

• Standalone Q1 2026, Q3 2025, and Q4 2025 income statement, cash flow, and balance sheet figures (only annual FY2025 and 6M/Q2 2026 interim data provided).
• Full quarterly balance sheets for March 31, 2026 and June 30, 2026 (10-Q 2026-06-30 filing truncated in provided materials).
• Detailed quarterly cash flow statements for Q2 2026 (only six-month aggregated sources/uses table in MD&A provided).
• Proved reserve quantities and standardized measure for June 30, 2026 (only annual December 31, 2025 data in 10-K).
• Hedging volumes and prices beyond December 31, 2025 (10-K Note 8) and the partial disclosure for 2026 in 10-Q Q2 2026 MD&A.